Impact of KRAS mutation on non-small cell lung cancer survival outcomes

被引：0

作者：

Thomas, Q. ^{[1
]}

Lemercier, P. ^{[2
]}

Justeau, G. ^{[3
]}

Schneider, S. ^{[4
]}

Filleron, T. ^{[5
]}

Masip, J. Remon ^{[6
]}

Perol, M. ^{[7
]}

Girard, N. ^{[8
]}

Debieuvre, D. ^{[9
]}

Valette, C. Audigier ^{[10
]}

Chouaid, C. ^{[11
]}

Loeb, A. ^{[12
]}

Hiret, S. ^{[13
]}

Clement-Duchene, C. ^{[14
]}

Dansin, E. ^{[15
]}

Stancu, A. T. ^{[16
]}

Dubray-Longeras, P. ^{[17
]}

Pichon, E. ^{[18
]}

Bosquet, L. ^{[19
]}

Quantin, X. ^{[1
]}

机构：

[1] ICM Inst Canc Montpellier, Dept Oncol, Montpellier, France

[2] ICM Inst Canc Montpellier, Biometr Unit, Montpellier, France

[3] CHU Angers, Pneumol, Angers, France

[4] Ctr Hosp Cote Basque, Pyrenees Atlant, Bayonne, France

[5] IUCT Oncopole, Haute Garonne, Inst Claudius Regaud, Toulouse, France

[6] Inst Gustave Roussy, Dept Oncol, Villejuif, France

[7] Ctr Leon Berard, Dept Med Oncol, Lyon, France

[8] Thorax Inst, Inst Curie, Paris, France

[9] GHRMSA, Pneumol, Mulhouse, France

[10] Hop Sainte Musse, Pneumol, Toulon, France

[11] CH Intercommunal Creteil, Pneumol, Creteil, France

[12] Ctr Henri Becquerel, Pneumol, Rouen, France

[13] ICO Inst Cancerol IOuest Rene Gauducheau, Dept Oncol, St Herblain, France

[14] Inst Cancerol Lorraine Alexis Vautrin, Dept Oncol, Vandoeuvre Les Nancy, France

[15] Ctr Oscar Lambret, Dept Oncol, Lille, France

[16] Inst Sainte Catherine, Pneumol, Avignon, France

[17] Ctr Jean Perrin, Pneumol, Clermont Ferrand, France

[18] CHRU Hop Tours, Pneumol, Hop Bretonneau, Tours, France

[19] UNICANCER, Real World Data, Paris, France

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.2433

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1401P

引用

页数：1

共 50 条

[21] Real world outcomes in KRAS G12C mutation positive non-small cell lung cancer
Cui, Wanyuan
Franchini, Fanny
Alexander, Marliese
Officer, Ann
Wong, Hui-Li
IJzerman, Maarten
Desai, Jayesh
Solomon, Benjamin J.
LUNG CANCER, 2020, 146 : 310 - 317
[22] Localised non-small cell lung cancer: patient characteristics and radical radiotherapy outcomes according to KRAS mutation status
Parreira, Ana Sofia de Freitas Matos
Brown, Kate
Carter, Matthew
Helen, Adderley
Faivre-Finn, Corinne
Lindsay, Colin Rowan
LUNG CANCER, 2025, 200
[23] Editorial: Factors that impact the survival of non-small cell lung cancer
Hegi-Johnson, Fiona
Higgins, Kristin A.
FRONTIERS IN ONCOLOGY, 2023, 13
[24] The Impact of Sex on Non-Small Cell Lung Cancer Survival in Canada
Ford-Sahibzada, C.
Dean, M.
Peters, C.
Brenner, D.
Gibson, A.
Tudor, R.
Elegbede, A.
D'Silva, A.
Cheung, W.
Bebb, G.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (10) : S946 - S947
[25] EVALUATION OF KRAS GENE MUTATION AND COPY NUMBER GAIN IN NON-SMALL CELL LUNG CANCER
Sasaki, Hidefumi
Okuda, Katsuhiro
Hikosaka, Yu
Moriyama, Satoru
Yano, Motoki
Fujii, Yoshitaka
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S945 - S945
[26] Sotorasib: First Approved KRAS Mutation Inhibitor for the Treatment of Non-small Cell Lung Cancer
De, Surya K. K.
CURRENT MEDICINAL CHEMISTRY, 2023, 30 (09) : 1000 - 1002
[27] KRAS mutation is highly correlated with EGFR alterations in patients with non-small cell lung cancer
Wang, J. -Y.
Lin, S. -R.
EJC SUPPLEMENTS, 2009, 7 (04): : 37 - 37
[28] Prevention of non-small cell lung cancer with kras mutation using a novel peptide vaccine
Wang, Suhe
Cao, Zhengyi
Chen, Jesse
Katarzyna, Janczak
Baker, James
CANCER RESEARCH, 2022, 82 (12)
[29] Evaluation of Kras Gene Mutation and Copy Number Gain in Non-small Cell Lung Cancer
Sasaki, Hidefumi
Hikosaka, Yu
Kawano, Osamu
Moriyama, Satoru
Yano, Motoki
Fujii, Yoshitaka
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (01) : 15 - 20
[30] A novel intranasal peptide vaccine inhibits non-small cell lung cancer with KRAS mutation
Su He Wang
Zhengyi Cao
Mohammad Farazuddin
Jesse Chen
Katarzyna W. Janczak
Shengzhuang Tang
Jayme Cannon
James R. Baker
Cancer Gene Therapy, 2024, 31 : 464 - 471

← 1 2 3 4 5 →